OXBDF News and Press, Oxford Biomedica

2026-06-09 08:12:09 ET Oxford Biomedica plc (OXBDF) Analyst/Investor Day June 2, 2026 9:00 AM EDT Company Participants Aurelie Charpentier Frank Mathias - CEO & Director Kyriacos Mitrophanous - Chief Innovation Officer Nicholas Clarkson Sebastien Ri...

2026-03-26 13:55:57 ET Oxford Biomedica plc (OXBDF) Q4 2025 Earnings Call March 26, 2026 9:00 AM EDT Company Participants Frank Mathias - CEO & Director Sebastien Ribault - Chief Business Officer Lucinda Crabtree - CFO & Director ... Read the full...

2026-03-26 10:41:32 ET More on Oxford Biomedica plc Oxford Biomedica plc 2025 Q4 - Results - Earnings Call Presentation Bristol-Myers, OXB sign multi-year CAR-T supply deal Historical earnings data for Oxford Biomedica plc Financial information for Oxford Bio...

2026-02-04 06:47:56 ET More on Bristol-Myers Squibb Bristol Myers Squibb: The Rerating Was Fast - The Proof Will Be Slow (Rating Downgrade) Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion 44th Annual J.P. Morgan Healthcare Conference ...

2025-09-23 10:23:48 ET Oxford Biomedica plc (OXBDF) Q2 2025 Earnings Call September 23, 2025 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: Oxford Biomedica plc (OXBDF) Q2 2025 Earnings Call Transcript

National Health Investors Inc. (NHI) is expected to report $1.13 for Q1 2025 Palomar Holdings Inc. (PLMR) is expected to report $1.45 for Q1 2025 Weave Communications Inc. (WEAV) is expected to report $-0.11 for Q1 2025 First National Bank Alaska (FBAK) is expected to report for Q1 20...

2025-04-09 11:28:13 ET Oxford Biomedica plc (OXBDF) Q4 2024 Earnings Conference Call April 09, 2025 08:00 AM ET Company Participants Frank Mathias - Chief Executive Officer Sebastien Ribault - Chief Business Officer Lucy Crabtree - Chief Financial Officer C...

2025-04-09 07:17:35 ET More on Oxford Biomedica plc Historical earnings data for Oxford Biomedica plc Financial information for Oxford Biomedica plc Read the full article on Seeking Alpha For further details see: Oxford Biomedica reports FY results; reaff...

2025-03-30 07:10:00 ET Summary The abrdn World Healthcare Fund outperformed its custom benchmark, driven by strong performances from uniQure, Oculis Holding, and New Amsterdam Pharma Company. Global equity markets dipped slightly, but optimism rose due to Trump's election win and ...